In this interview discover further details of the JAVELIN Merkel 200 that led to the approval of the first immunotherapy treatment indicated in the EU and the first US FDA-approved systemic therapy for merkel cell carcinoma.
Browsing: Clinical trials
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center (NC, USA) are developing a potential new immunotherapy strategy for melanoma.
A novel ‘labyrinth’ chip is isolating cancer cells from the blood of patients with an aggressive form of breast cancer in a clinical trial.
What is the potential clinical significance of the results of the FLAURA trial presented at ESMO? Find out in our exclusive interview.
A nationwide study across Ireland revealed that the vast majority of patients do not understand the core concepts underpinning a clinical trial.
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
A recent clinical trial presents new data indicating durvalumab improves progression-free survival in patients with stage III non-small-cell lung cancer (NSCLC).
This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
In this interview with Francesco Lo-coco we discussed a randomized clinical trial conducted with the drug Trisenox as well as, the genetic characterization, monitoring and treatment of hematologic tumors, particularly acute promyelocytic leukemia.
What are the current limitation with clinical trials for AML? This review discusses trial end points, patient enrollment, cost of drug discovery and patient heterogeneity and future treatment of AML.